Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

0Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above analysis.

Cite

CITATION STYLE

APA

Nuñez de Villavicencio-Diaz, T., Ramos Gómez, Y., Oliva Argüelles, B., Fernández Masso, J. R., Rodríguez-Ulloa, A., Cruz García, Y., … Guerra Vallespi, M. (2015). Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells. Data in Brief, 4, 468–473. https://doi.org/10.1016/j.dib.2015.06.024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free